November 12, 2004 1/5 No: SN. 064/2019 Aug 9, 2019 Subject: Clarification of Operating Results and Financial Status of Quarter 3 ended June 30, 2019 Attention: President The Stock Exchange of

-1- AIT (VP-SEC) 018E/2018 August 9, 2018 Subject: Management's Discussion and Analysis of Operating Results for Q2-2018 To: The President of The Stock Exchange of Thailand Summary of Operations Q2

ended June 30, 2018 Attention: President The Stock Exchange of Thailand Oishi Group Public Company Limited and subsidiaries clarify consolidated operating results and consolidated financial statements for

(Translation) NEP-AC 002/2563 14 May 2020 Subject: Management Discussion and Analysis for Q1 end of 31 March 2020 To : The President The Stock Exchange of Thailand Operating Result NEP Realty and

1 Year 2020 (Million Baht) + (-)Q1 Total comprehensive income (loss) attributable to owners of the parent Operating Profit (Loss) EBIT Net Profit (Loss) Total Comprehensive income for ther period

November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries

Management Discussion and Analysis for the third quarter ended September 30, 2019 Attention The President The Stock Exchange of Thailand Attachment Report and interim financial statement for the third quarter

-1- AIT (VP-SEC) 017E/2024 8 August 2024 Subject: Management's Discussion and Analysis of Operating Results for Q2-2024 To: The President of the Stock Exchange of Thailand Summary of Operations Q1

policy to mitigate currency risk using hedging instruments where applicable. Other Income (expense) was Bt362mn, decreasing -29% YoY due to one-time gain in 3Q23 (Rabbit Line Pay divestment) and decreasing

% yoy) because EBITDA from FA business was lower due to stock loss as CPKO price drop. Moreover, the company recognized profit of THB 20 million from investments in the Thai Ethoxylate Company Limited